tirzepatide weight regain after stopping the withdrawal of (Zepbound) may wipe out many of the cardiometabolic gains made during weight loss, a post-hoc analysis of the SURMOUNT-4 trial indicated. Read more at: https://www.medpagetoday.com/endocrinology/obesity GLP-1 receptor agonists and tirzepatide

It's sterile water containing 0.9% benzyl alcohol, which acts as a preservative

Check our guide on what to expect your first week on semaglutide for practical tips

Clinical Points GLP-1 receptor agonists (GLP-1 RAs), such as exenatide, demonstrated efficacy in reducing heavy drinking days and total alcohol intake in individuals with obesity-related alcohol use disorders, suggesting a potential role for GLP-1 RAs in targeted treatments for alcohol dependency, particularly in patients with specific metabolic profiles

A comprehensive evaluation should include provider expertise, medication sourcing transparency, and tools to personalize your treatment

Both semaglutide and tirzepatide have been on the shortage list at various points, which has allowed compounding pharmacies to produce these medications legally